Anna Kazanchyan, Director at Foamix Pharmaceuticals Ltd. (FOMX), sold 808 shares at $2.31 ($2K) on 2019-07-15, disclosed to the SEC on 2019-07-17.
Scheduled sale ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |